Jianping Zhu Selected Research

Jianping Zhu Research Topics

Disease

9	Neoplasms (Cancer) 12/2022 - 10/2014
5	Inflammation (Inflammations) 12/2022 - 09/2020
3	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2014
2	Wounds and Injuries (Trauma) 11/2023 - 03/2013
2	Critical Illness (Critically Ill) 06/2023 - 01/2023
2	Ischemic Stroke 12/2021 - 11/2020
1	Infections 02/2024
1	Cardiotoxicity 01/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2023
1	COVID-19 10/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022
1	Chemical and Drug Induced Liver Injury 07/2022
1	Poisoning 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Atrophy 01/2022
1	Dyskinesias (Dyskinesia) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Epilepsy (Aura) 01/2022
1	Gliosis 01/2022
1	Herpes Zoster 01/2022
1	Seizures (Absence Seizure) 01/2022
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2021
1	Hepatic Encephalopathy 05/2021
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021
1	Esophageal Squamous Cell Carcinoma 01/2021
1	Vascular Diseases (Vascular Disease) 12/2020
1	Ischemia 11/2020
1	Brain Edema (Cerebral Edema) 11/2020
1	Infarction (Infarctions) 11/2020
1	Reperfusion Injury 09/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2020
1	Parkinson Disease (Parkinson's Disease) 02/2020
1	Neuroblastoma 02/2020
1	Polyps 01/2020
1	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 01/2020

Drug/Important Bio-Agent (IBA)

3	Therapeutic UsesIBA 02/2020 - 10/2014
2	Vancomycin FDA LinkGeneric 06/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 12/2022 - 10/2022
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022 - 01/2022
2	PlatinumIBA 01/2022 - 01/2019
2	diplatinIBA 01/2022 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2021 - 04/2020
2	JLX001IBA 11/2020 - 09/2020
1	Ligases (Synthetase)IBA 02/2024
1	lipoteichoic acidIBA 02/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2024
1	MetalsIBA 11/2023
1	salicylhydroxamic acid (SHAM)IBA 01/2023
1	EstersIBA 01/2023
1	OrganophosphatesIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Codon (Codons)IBA 12/2022
1	VaccinesIBA 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Tigecycline (Tygacil)FDA Link 07/2022
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2022
1	HyoscyamineIBA 01/2022
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2022
1	Shen-FuIBA 01/2022
1	N 30IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Diazepam (Valium)FDA LinkGeneric 01/2022
1	Kainic Acid (Kainate)IBA 01/2022
1	Levodopa (L Dopa)FDA LinkGeneric 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	Pentobarbital (Nembutal)FDA Link 01/2022
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2022
1	Platelet Activating FactorIBA 12/2021
1	InflammasomesIBA 12/2021
1	Oxygen (Dioxygen)IBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2021
1	Succinic Acid (Succinate)IBA 07/2021
1	Polyethylene (Polythene)IBA 07/2021
1	tocophersolanIBA 07/2021
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 07/2021
1	Tocopherols (Tocopherol)IBA 07/2021
1	AlbuminsIBA 07/2021
1	LipidsIBA 07/2021
1	ginkgolide BIBA 05/2021
1	toripalimabIBA 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 12/2020
1	cyclovirobuxine DIBA 11/2020
1	Nanoparticle Drug Delivery SystemIBA 04/2020
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 04/2020
1	Pramipexole (Mirapex)FDA LinkGeneric 02/2020
1	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 02/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2020
1	hydrogen sulfite (bisulfite)IBA 01/2020
1	maxingshiganIBA 01/2020
1	SolutionsIBA 01/2020
1	SuspensionsIBA 01/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2021 - 10/2014
2	Stents 11/2023 - 05/2021
2	Therapeutics 01/2021 - 04/2020
2	Neoadjuvant Therapy 01/2021 - 03/2015
1	Continuous Renal Replacement Therapy 01/2023
1	Adjuvant Chemotherapy 01/2021